decisionhealth Newsletters, Coder Pink Sheets - 2002 Issue 8 (August)
New code set for sodium hyaluronate injections
Subscribe or sign in to view the full article.
Article Overview
This article covers a CMS update for sodium hyaluronate injection coding, including the move from one HCPCS code to a newly created temporary Q code, the timing of the transition, and the operational impact on claim submission and carrier processing. It is relevant to medical billing staff, coders, and practices that report injectable drugs under HCPCS and need to understand effective dates, carrier readiness, and interim billing workflow changes.
Why This Topic Matters
The article helps practices track a coding transition that affects how injections are reported and when claims may be accepted by carriers. It is important for avoiding rejected claims and understanding how temporary HCPCS changes are handled during a delayed implementation period.
Article Sections
-
New code set for sodium hyaluronate injections
Overview of the coding update for sodium hyaluronate injections and the transition to a new temporary HCPCS code. The section also addresses timing, carrier processing, and claim submission considerations.
What You Will Learn
- How the article frames the HCPCS coding update for sodium hyaluronate injections
- What operational issues are associated with the transition period and carrier processing
- Why temporary HCPCS codes may later be replaced by permanent codes
- How the article presents the claim-submission timeline for the coding change
Who Should Read This
- Medical coders
- Billing staff
- Practice managers
- Revenue cycle professionals
- Healthcare providers billing injectable drugs
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com